History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Yankees Universe Fund Fred's Team Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook
Press Releases Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online

Memorial Sloan-Kettering Cancer Center is one of the world's premier institutions for cancer treatment and research. Memorial Sloan-Kettering Cancer Center's technologies focus on cancer and associated diseases, as well as on ongoing biomedical research.

Listed here are some of our current technologies available for license, divided into the following categories: devices, diagnostics, research tools, therapeutics, and vaccines. The list is not exhaustive. Some of our newest technologies may not appear on our Web site. We encourage you to contact us to speak to one of our Licensing Associates about your particular interests.

  • Full Listing
    A full listing of our devices, diagnostics, research tools, therapeutics, and vaccines available for licensing.
  • Devices
    Equipment, apparatus, instruments designed to be used for therapeutics, diagnostics, patient care, or research purposes.
  • Diagnostics
    Technologies designed to assist in the detection, diagnosis, monitoring, and prognosis of cancer, as well as in determining susceptibility to them.
  • Research Tools
    Tools to help further investigations in therapeutic, diagnostic, and basic research. They can be targets to be used for drug discovery, chemical or biological materials, or methods for basic and applied research.
  • Therapeutics
    Technologies designed for the treatment of cancer and associated diseases. These include small molecules, biologics, and cell and gene therapies.
  • Vaccines
    Therapeutic vaccines are designed to stimulate the body's immune system to combat cancer.
Last Updated: Apr. 3, 2008
PrintEmail This Page